Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Forkhead box protein G1 (FOXG1) is a transcriptional repressor of the forkhead box (FOX) family, featuring a distinct forkhead DNA-binding domain. It is critically important in embryonic brain development, especially for the telencephalon, which forms major forebrain structures such as the cerebrum. FOXG1 directs numerous neurodevelopmental processes including neuron differentiation, neuroblast proliferation, and regional brain patterning. Pathogenic mutations in FOXG1 cause FOXG1 syndrome, a congenital variant of Rett syndrome that results in early infantile neurodevelopmental abnormalities, brain structural defects, and often severe intellectual disability and seizures. FOXG1 also interacts with chromatin regulators such as JARID1B and may play a role as an oncogenic factor in cancers like glioblastoma by promoting proliferation and inhibiting differentiation[1][2][3][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Forkhead box protein G1 (FOXG1).